Centocor revolutionized the science of immunology and has been a leader in the field of cancer and immune-disorders for over 20 years.
800/850 Ridgeview Drive
Pennsylvania, United States
|2010-02-25||Five Prime Therapeutics||Project Finance|
|2007-01-22||Five Prime Therapeutics||Partnership||$15M||Johnson & Johnson Innovation|
|2006-02-17||Accriva Diagnostics||Series C||$8.25M||Apax Partners, EW Healthcare Partners, Johnson & Johnson Innovation, Kaiser Permanente Ventures, KB Partners, Kleiner Perkins Caufield & Byers, Medicus Venture Partners, Point72 Asset Management, PTV Sciences, RiverVest Venture Partners, and Techno-Venture|
|2001-10-08||3 Dimensional Pharmaceuticals||Milestone Payment||$4M|